In silico analysis of Single Nucleotide Polymorphisms (SNPs) in human BRAF gene

Gene

Volumn 508, Issue 2, 2012, Pages 188-196

  Hussain, Muhammad Ramzan Manwar ^a,b   Shaik, Noor Ahmad ^b   Al Aama, Jumana Yousuf ^b   Asfour, Hani Z ^b   Subhani Khan, Fatima ^c   Masoodi, Tariq Ahmad ^d   Khan, Muhammad Akhtar ^b   Shaik, Nazia Sultana ^e  

^a Institute of Molecular Sciences and Bioinformatics Lahore   (Pakistan)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^c INTERNATIONAL ISLAMIC UNIVERSITY   (Pakistan)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

^e K L UNIVERSITY   (India)

Author keywords

BRAF gene; Genomics; In silico analysis; Pathogenic variants; Single Nucleotide Polymorphism

Indexed keywords

B RAF KINASE;

AMINO ACID SUBSTITUTION; ARTICLE; BRAF GENE; COMPUTER MODEL; GENE; GENE MUTATION; GENOMICS; HUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN STABILITY; PROTEIN STRUCTURE; SINGLE NUCLEOTIDE POLYMORPHISM;

COMPUTATIONAL BIOLOGY; DISEASE; HUMANS; MODELS, MOLECULAR; MOLECULAR DYNAMICS SIMULATION; MUTATION; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN CONFORMATION; PROTO-ONCOGENE PROTEINS B-RAF; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84865763517     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.07.014     Document Type: Article

References (33)

1. Abagyan R., Totrov M. Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. J. Mol. Biol. 1994, 235:983-1002.
2. Balch C.M., et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J. Clin. Oncol. 2001, 19:3635-3648.
3. Calabrese R., et al. Functional annotations improve the predictive score of human disease-related mutations in proteins. Hum. Mutat. 2009, 30:1237-1244.
4. Cavallo A., Martin A.C. Mapping SNPs to protein sequence and structure data. Bioinformatics 2005, 8:1443-1450.
5. Davies H., et al. Mutations of the BRAF gene in human cancer. Nature 2002, 417:949-954.
6. El-Osta H., et al. BRAF mutations in advanced cancers: clinical characteristics and outcomes. PLoS One 2011, 6(10):e25806.
7. Fredman D., et al. HGVbase: a human sequence variation database emphasizing data quality and a broad spectrum of data sources. Nucleic Acids Res. 2002, 30:387-391.
8. Garnett M.J., Marais R. Guilty as charged: B-RAF is a human oncogene. Cancer Cell 2004, 6:313-319.
9. Greenman C., et al. Patterns of somatic mutation in human cancer genomes. Nature 2007, 446:153-158.
10. Hingorani S.R., et al. Suppression of BRAF(V599E) in human melanoma abrogates transformation. Cancer Res. 2003, 63:5198-5202.
11. Ikenoue T., et al. Rapid detection of mutations in the BRAF gene using real-time polymerase chain reaction and melting curve analysis. Cancer Genet. Cytogenet. 2004, 149:68-71.
12. Jemal A., Devesa S.S., Hartge P., Tucker M.A. Recent trends in cutaneous melanoma incidence among whites in the United States. J. Natl. Cancer Inst. (Bethesda) 2001, 93:678-683.
13. Lovell S.C., et al. Structure validation by Calpha geometry: phi, psi and Cbeta deviation. Protein Struct. Funct. Genet. 2002, 50:437-450.
14. Melo F., Feytmans E. Assessing protein structures with a non-local atomic interaction energy. J. Mol. Biol. 1998, 277:1141-1152.
15. Ng P.C., Henikoff S. Predicting deleterious amino acid substitutions. Genome Res. 2001, 11:863-874.
16. Petersen B., et al. A generic method for assignment of reliability scores applied to solvent accessibility predictions. BMC Struct. Biol. 2009, 9:51. 10.1186/1472-6807-9-51.
17. Pettersen E.F., et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 2004, 25:1605-1612.
18. Pratilas C.A., Solit D.B. Therapeutic strategies for targeting BRAF in human cancer. Rev. Recent Clin. Trials 2007, 2(2):121-134.
19. Rajagopalan H., et al. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 2002, 418:934-934.
20. Rajasekaran R., et al. Identification and in silico analysis of functional SNPs of the BRCA1 gene. Genomics 2007, 90:447-452.
21. Ramensky V., Bork P., Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 2002, 30:3894-3900.
22. Rodriguez-Viciana P., et al. Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science 2006, 311:1287-1290.
23. Roy A., Kucukural A., Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat. Protoc. 2010, 5:725-738.
24. Sarkozy A., et al. Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum. Hum. Mutat. 2009, 30:695-702.
25. Schulz A.L., et al. Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome. Clin. Genet. 2008, 73:62-70.
26. Schymkowitz J., et al. The FoldX web server: an online force field. Nucleic Acids Res. 2005, 33:W382-W388.
27. Sjoeblom T., et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006, 314:268-274.
28. Smigielski E.M., et al. dbSNP: a database of single nucleotide polymorphisms. Nucleic Acids Res. 2000, 28:352-355.
29. Thomas P.D., et al. PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acids Res. 2003, 31:334-341.
30. Venselaar H., Te Beek T.A., Kuipers R.K., Hekkelman M.L., Vriend G. Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinformatics 2010, 11:548.
31. Wu S., Zhang Y. MUSTER: improving protein sequence profile-profile alignments by using multiple sources of structure information. Proteins 2008, 72:547-556.
32. Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 2008, 9:40.
33. Zhang, Skolnick Scoring function for automated assessment of protein structure template quality. Proteins 2004, 57:702-710.